{"transactions":[{"id":3495383,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2019-06-10T20:55:59.000Z","date":"2019-06-07","kind":"purchase","acquired":true,"shares":65468,"price":3.02,"value":197713.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $3.20, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":1056031,"source":{"system":"sec-edgar","filing":"0001104659-19-034633","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/a4.xml","form_type":"4"}},{"id":3495382,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2019-06-10T20:55:59.000Z","date":"2019-06-06","kind":"purchase","acquired":true,"shares":59000,"price":2.8,"value":165200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.73 to $2.88, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":990563,"source":{"system":"sec-edgar","filing":"0001104659-19-034633","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465919034633/a4.xml","form_type":"4"}},{"id":3498428,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2019-06-06T22:09:08.000Z","date":"2019-06-05","kind":"purchase","acquired":true,"shares":32852,"price":2.91,"value":95599.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.87 to $2.97, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":931563,"source":{"system":"sec-edgar","filing":"0001104659-19-034353","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/a4.xml","form_type":"4"}},{"id":3498427,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman of the Board"}}],"security":"Common Stock","published_at":"2019-06-06T22:09:08.000Z","date":"2019-06-04","kind":"purchase","acquired":true,"shares":12928,"price":2.92,"value":37749.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.89 to $2.95, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":898711,"source":{"system":"sec-edgar","filing":"0001104659-19-034353","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465919034353/a4.xml","form_type":"4"}},{"id":3703246,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T23:28:09.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":200000,"derivative":{"exercise_price":4.1,"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-19-000891","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465919000891/a4.xml","form_type":"4"}},{"id":4078634,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-02T21:33:50.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":130000,"derivative":{"exercise_price":5.47,"expiration_date":"2028-01-30","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001104659-18-006256","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465918006256/a4.xml","form_type":"4"}},{"id":4122231,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Exec Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-22T21:37:13.000Z","date":"2017-12-21","kind":"exercise","acquired":false,"shares":106382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted on January 31, 2013, and vested over four years with (i) approximately 25.2% of the shares underlying the option vesting on February 1, 2014, (ii) approximately 3.7% vesting monthly from January 1, 2015 to July 1, 2015, (iii) approximately 3.5% vesting on August 1, 2015, (iv) approximately 3.7% vesting monthly from January 1, 2016 to October 1, 2016, (v) approximately 0.8% vesting on November 1, 2016, and (vi) approximately 3.7% vesting monthly from January 1, 2017 to February 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":2.73,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":106382},"source":{"system":"sec-edgar","filing":"0001104659-17-074880","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465917074880/a4.xml","form_type":"4"}},{"id":4122230,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Exec Chairman of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-22T21:37:13.000Z","date":"2017-12-21","kind":"exercise","acquired":false,"shares":83011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted on January 31, 2013, and vested over four years with (i) approximately 24.7% of the shares underlying the option vesting on February 1, 2014, (ii) approximately 4.8% vesting monthly from March 1, 2014 to December 1, 2014, (iii) approximately 0.3% vesting on August 1, 2015, (iv) approximately 4.8% vesting monthly from September 1, 2015 to December 1, 2015, (v) approximately 3.7% vesting on November 1, 2016, and (vi) approximately 4.8% vesting on December 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.49,"expiration_date":"2023-01-30","underlying":"Common Stock","underlying_shares":83011},"source":{"system":"sec-edgar","filing":"0001104659-17-074880","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465917074880/a4.xml","form_type":"4"}},{"id":4122229,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Exec Chairman of the Board"}}],"security":"Common Stock","published_at":"2017-12-22T21:37:13.000Z","date":"2017-12-21","kind":"exercise","acquired":true,"shares":106382,"price":2.73,"value":290422.86,"ownership":{"direct":true},"balance_after":885783,"source":{"system":"sec-edgar","filing":"0001104659-17-074880","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465917074880/a4.xml","form_type":"4"}},{"id":4122228,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Exec Chairman of the Board"}}],"security":"Common Stock","published_at":"2017-12-22T21:37:13.000Z","date":"2017-12-21","kind":"exercise","acquired":true,"shares":83011,"price":2.49,"value":206697.39,"ownership":{"direct":true},"balance_after":779401,"source":{"system":"sec-edgar","filing":"0001104659-17-074880","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465917074880/a4.xml","form_type":"4"}},{"id":4155951,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Exec. Chairman of the Board"}}],"security":"Common Stock","published_at":"2017-11-20T13:04:14.000Z","date":"2017-11-16","kind":"purchase","acquired":true,"shares":19000,"price":5.18,"value":98420.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.13 to $5.19, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":696390,"source":{"system":"sec-edgar","filing":"0001104659-17-069533","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465917069533/a4.xml","form_type":"4"}},{"id":4456800,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-10T21:34:01.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":235000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":235000,"derivative":{"exercise_price":6.56,"expiration_date":"2027-01-30","underlying":"Common Stock","underlying_shares":235000},"source":{"system":"sec-edgar","filing":"0000899243-17-003490","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000089924317003490/doc4.xml","form_type":"4"}},{"id":4518493,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":156848,"kind":"person","name":"Sawhney Amarpreet","position":1,"cik":"0001614417","reported_name":"Sawhney Amarpreet","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-16T21:04:08.000Z","date":"2016-12-15","kind":"purchase","acquired":true,"shares":45300,"price":7.85,"value":355605.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.39 to $8.04, inclusive. The reporting person undertakes to provide to Ocular Therapeutix, Inc., any security holder of Ocular Therapeutix, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":677390,"source":{"system":"sec-edgar","filing":"0000899243-16-035752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000089924316035752/doc4.xml","form_type":"4"}}]}